Koyfin Home > Directory > Health Care > Amphastar Pharma > Total Debt / Capital

Amphastar Pharma Total Debt / Capital Chart (AMPH)

Amphastar Pharma annual/quarterly Total Debt / Capital from 2014 to 2018.
  • Amphastar Pharma Total Debt / Capital for the quarter ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Capital for the last 12 months ending December 12, 2018 was $12m a -1.34% decrease of 0m year over year
  • Amphastar Pharma Annual Total Debt / Capital for 2018 was $12m a -5.50% decrease of -1m from 2017
  • Amphastar Pharma Annual Total Debt / Capital for 2017 was $13m a 19.56% increase of 2m from 2016
  • Amphastar Pharma Annual Total Debt / Capital for 2016 was $10m a -18.78% decrease of -2m from 2015
Other Ratios Metrics:
  • Amphastar Pharma Other Liabilities for the quarter ending December 12, 2018 was $10m a -0.42% decrease of 0m year over year
  • Amphastar Pharma Total Debt / Equity for the quarter ending December 12, 2018 was $14m a -1.53% decrease of 0m year over year
View Chart On Koyfin

Quarterly AMPH Total Debt / Capital Data

12/2018$12m
09/2018$13m
06/2018$14m
03/2018$12m
12/2017$12m
09/2017$13m
06/2017$12m
03/2017$10m
12/2016$10m
09/2016$12m

Annual AMPH Total Debt / Capital Data

2018$12m
2017$13m
2016$10m
2015$12m
2014$13m
2013$11m